These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6307012)

  • 1. Virus-immune T cells and monoclonal antibodies in the mouse influenza model.
    Doherty PC; Greenspan N; Lopes AD; Gerhard W
    Adv Exp Med Biol; 1983; 162():441-7. PubMed ID: 6307012
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune responses to influenza virus in the mouse, and their role in control of the infection.
    Virelizier JL; Allison AC; Schild GC
    Br Med Bull; 1979 Jan; 35(1):65-8. PubMed ID: 367489
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular immune responses of mice to influenza virus infection.
    Reiss CS; Schulman JL
    Cell Immunol; 1980 Dec; 56(2):502-9. PubMed ID: 6258809
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses.
    Zweerink HJ; Courtneidge SA; Skehel JJ; Crumpton MJ; Askonas BA
    Nature; 1977 May; 267(5609):354-6. PubMed ID: 194164
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunologic recognition of influenza virus-infected cells. I. Generation of a virus-strain specific and a cross-reactive subpopulation of cytotoxic T cells in the response to type A influenza viruses of different subtypes.
    Braciale TJ
    Cell Immunol; 1977 Oct; 33(2):423-36. PubMed ID: 303150
    [No Abstract]   [Full Text] [Related]  

  • 6. Roles of influenza virus infectivity and glycosylation of viral antigen for recognition of target cells by cytolytic T lymphocytes.
    Ertl H; Ada GL
    Immunobiology; 1981; 158(3):239-53. PubMed ID: 6971249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccinating effect of conjugates of influenza virus surface antigens with a synthetic polymer carrier].
    Petrov RV; Zhdanov VM; Kabanov VA; Khaitov RM; Norimov ASh
    Dokl Akad Nauk SSSR; 1984; 277(3):752-5. PubMed ID: 6489120
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunodeficient mouse models in the characterization of the protective immunity to influenza virus.
    Bot A; Isobe H; Bona C
    Folia Microbiol (Praha); 1998; 43(5):477-8. PubMed ID: 9821301
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene.
    Bot A; Antohi S; Bot S; Garcia-Sastre A; Bona C
    Int Immunol; 1997 Nov; 9(11):1641-50. PubMed ID: 9418125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T-cell and antibody responses to influenza infection of mice.
    Wells MA; Ennis FA; Daniel S
    J Gen Virol; 1979 Jun; 43(3):685-90. PubMed ID: 314495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different functions of subsets of effector T cells in murine influenza virus infection.
    Leung KN; Ada GL
    Cell Immunol; 1982 Mar; 67(2):312-24. PubMed ID: 6979396
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytotoxic T cells to type A influenza virus; viral hemagglutinin induces A-strain specificity while infected cells confer cross-reactive cytotoxicity.
    Zweerink HJ; Askonas BA; Millican D; Courtneidge SA; Skehel JJ
    Eur J Immunol; 1977 Sep; 7(9):630-5. PubMed ID: 303568
    [No Abstract]   [Full Text] [Related]  

  • 13. An analysis of effector T cell generation and function in mice exposed to influenza A or Sendai viruses.
    Ada GL; Leung KN; Ertl H
    Immunol Rev; 1981; 58():5-24. PubMed ID: 6273293
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term T-cell-mediated immunity to Epstein-Barr virus.
    Rickinson AB; Moss DJ; Wallace LE; Rowe M; Misko IS; Epstein MA; Pope JH
    Cancer Res; 1981 Nov; 41(11 Pt 1):4216-21. PubMed ID: 6272965
    [No Abstract]   [Full Text] [Related]  

  • 15. Modification of cytotoxic T-cell response patterns by administration of hemagglutinin-specific monoclonal antibodies to mice infected with influenza A viruses.
    Greenspan N; Doherty PC
    Hybridoma; 1982; 1(2):149-59. PubMed ID: 6092263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity and specificity of cloned lines of influenza-virus specific cytotoxic T lymphocytes.
    Braciale TJ; Andrew ME; Braciale VL
    J Exp Med; 1981 Apr; 153(4):910-23. PubMed ID: 6166708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell mediated immunity in experimental influenza and parainfluenza infection.
    Anderson MJ; Heath RB
    Dev Biol Stand; 1977 Jun 1-3; 39():379-83. PubMed ID: 203505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells.
    Scherle PA; Palladino G; Gerhard W
    J Immunol; 1992 Jan; 148(1):212-7. PubMed ID: 1530795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of regulator cells induced by the influenza virus in adoptive transfer].
    Volgarev AP; Maĭorova LP; Smorodintsev AA
    Biull Eksp Biol Med; 1987 Jan; 103(1):83-6. PubMed ID: 2879578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differentiated study of specific antibody populations as a possible way to increase the prognostic value of indicators of humoral immunity in influenza].
    Meringova LF; Iakovleva IV; Voĭtsekhovskiĭ BL; Dukhin AI; Poliak RIa
    Vestn Akad Med Nauk SSSR; 1989; (11):75-80. PubMed ID: 2623938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.